The Impact of Incretin-Based Therapies on Anthropometric and Metabolic Parameters in Women with Polyendocrine Metabolic Ovarian Syndrome
Diabetes, Metabolic Syndrome and Obesity · 2026-10 · Volume 19 · 1-17
DOI: 10.2147/dmso.s620819 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-10. Verfasst von Andrijana Koceva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetology, University Medical Center Maribor, Maribor, Slovenia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Diabetology, University Medical Center Maribor, Maribor, Slovenia.
- Faculty of Medicine, University of Maribor, Maribor, Slovenia.
- Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Zitieren
APA
Koceva, A., Janež, A., & Jensterle, M. (2026). The Impact of Incretin-Based Therapies on Anthropometric and Metabolic Parameters in Women with Polyendocrine Metabolic Ovarian Syndrome. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-17. https://doi.org/10.2147/dmso.s620819
Vancouver
Koceva A, Janež A, Jensterle M. The Impact of Incretin-Based Therapies on Anthropometric and Metabolic Parameters in Women with Polyendocrine Metabolic Ovarian Syndrome. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-17. doi:10.2147/dmso.s620819
BibTeX
@article{Koceva2026,
author = {Koceva, Andrijana and Janež, Andrej and Jensterle, Mojca},
title = {The Impact of Incretin-Based Therapies on Anthropometric and Metabolic Parameters in Women with Polyendocrine Metabolic Ovarian Syndrome},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--17},
doi = {10.2147/dmso.s620819}
}
EUVIMED